Preeclampsia: Essential Guide To Symptoms, Risks, Treatment

Preeclampsia is a serious pregnancy complication characterized by high blood pressure and often protein in the urine, typically developing after 20 weeks of gestation. It affects 2-8% of pregnancies worldwide and poses significant risks to both mother and baby if not managed promptly.

What Is Preeclampsia?

Preeclampsia, also known as toxemia, is a hypertensive disorder unique to pregnancy and the postpartum period. It involves new-onset hypertension (blood pressure ≥140/90 mm Hg) after 20 weeks, usually accompanied by proteinuria (≥0.3 g/24 hours) or signs of organ damage such as kidney, liver, or brain issues. Without symptoms, it is often detected during routine prenatal visits. The condition represents a spectrum from gestational hypertension to severe forms like eclampsia (seizures) or HELLP syndrome (hemolysis, elevated liver enzymes, low platelets).

This disorder complicates 5-8% of U.S. births and contributes to 15% of preterm deliveries. Globally, it causes over 50,000 maternal deaths and 500,000 fetal deaths annually, making it a leading cause of maternal and perinatal mortality.

Symptoms of Preeclampsia

Many women with preeclampsia experience no noticeable symptoms, relying on prenatal checkups for detection. When symptoms occur, they may include:

• High blood pressure (≥140/90 mm Hg)
• Proteinuria or other kidney damage indicators
• Severe headaches
• Vision changes like blurred vision or light sensitivity
• Upper abdominal pain, especially under the ribs
• Shortness of breath due to fluid in lungs
• Swelling (edema) in hands, face, or legs (though common in pregnancy, sudden or severe swelling warrants attention)
• Nausea or vomiting after the first trimester
• Sudden weight gain

Severe features signaling urgent care include blood pressure ≥160/110 mm Hg, thrombocytopenia (<100,000 platelets/μL), impaired liver function (elevated transaminases twice normal), renal insufficiency (creatinine >1.1 mg/dL), pulmonary edema, or new-onset cerebral/visual disturbances.

Causes and Risk Factors

The exact cause of preeclampsia remains unclear, but it involves placental dysfunction leading to endothelial damage and systemic inflammation. Two subtypes exist: early-onset (placental, before 34 weeks) due to defective trophoblast invasion causing ischemia, and late-onset (maternal, after 34 weeks) linked to maternal vascular issues with a healthier placenta.

Risk factors increase susceptibility:

• First pregnancy
• History of preeclampsia
• Chronic hypertension, kidney disease, or diabetes
• Multiple gestation (twins or more)
• Age <18 or >35
• Obesity (BMI ≥30)
• Family history of preeclampsia
• In vitro fertilization (IVF)
• Autoimmune disorders like lupus or antiphospholipid syndrome

Chronic hypertension with superimposed preeclampsia worsens outcomes.

Preeclampsia vs. Other Hypertensive Disorders

These distinctions guide diagnosis and management.

Diagnosis

Diagnosis relies on blood pressure measurements (≥140/90 mm Hg on two occasions), proteinuria, or organ dysfunction after 20 weeks. Tests include:

• Urine protein/creatinine ratio or 24-hour collection
• Blood tests for liver enzymes, platelets, creatinine
• Ultrasound for fetal growth and amniotic fluid
• Non-stress test or biophysical profile for fetal well-being

Early-onset (<34 weeks) and postpartum preeclampsia (up to 6 weeks post-delivery) require vigilant monitoring.

Complications

Untreated preeclampsia can lead to severe issues:

• Maternal: Eclampsia (seizures, even without prior symptoms), HELLP syndrome, stroke, organ failure (kidney, liver, brain), pulmonary edema, placental abruption, cardiovascular disease later in life.
• Fetal: Preterm birth (<37 weeks, risking respiratory issues, developmental delays), growth restriction, stillbirth, low birth weight.

Postpartum preeclampsia affects 5-10% of cases, occurring days to weeks after delivery.

Treatment and Management

The only cure is delivery, timed by severity and gestation. Management includes:

Antihypertensives: For severe hypertension (≥160/110 mm Hg), use IV labetalol, hydralazine, or oral nifedipine. Maintenance with labetalol, nifedipine, or methyldopa.

Magnesium Sulfate: Prevents seizures in severe cases, continued 24 hours postpartum.

Expectant Management: For <34 weeks without severe features, involves hospitalization, frequent monitoring, corticosteroids for fetal lung maturity.

Delivery: Immediate for ≥34 weeks or severe features; vaginal if possible, cesarean if needed.

Postpartum monitoring is crucial, especially for chronic hypertension.

Prevention

No guaranteed prevention, but strategies reduce risk:

• Low-dose aspirin (81 mg daily) from 12 weeks for high-risk women
• Calcium supplementation if low dietary intake
• Regular prenatal care with BP and urine checks
• Healthy lifestyle: weight management, exercise, balanced diet
• Control pre-existing conditions

Early screening identifies at-risk pregnancies.

Long-Term Risks

Women with preeclampsia face 2-4 times higher risk of future hypertension, stroke, heart disease, and kidney issues. Offspring may have higher cardiovascular risks. Lifelong follow-up with primary care is recommended.

Frequently Asked Questions (FAQs)

What are the early signs of preeclampsia?

Early signs include high blood pressure, protein in urine, headaches, vision changes, and upper abdominal pain, often found at prenatal visits.

Can preeclampsia occur after delivery?

Yes, postpartum preeclampsia can develop within days to weeks after birth, requiring prompt medical attention.

How is preeclampsia treated before 37 weeks?

Expectant management with blood pressure control, magnesium sulfate, and fetal monitoring until delivery is feasible.

Who is at higher risk for preeclampsia?

High-risk groups include first-time mothers, those with chronic hypertension, multiples, obesity, or family history.

Does preeclampsia go away after delivery?

Blood pressure and symptoms usually resolve within days to weeks, but monitoring is needed for complications.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb